Icon (NASDAQ:ICLR) and ALGAE TEC LTD/S (OTCMKTS:ALGXY) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, earnings and dividends.
This table compares Icon and ALGAE TEC LTD/S’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|ALGAE TEC LTD/S||N/A||N/A||N/A|
Valuation and Earnings
This table compares Icon and ALGAE TEC LTD/S’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Icon||$1.76 billion||4.16||$281.48 million||$5.39||25.09|
|ALGAE TEC LTD/S||$2.05 million||1.54||-$6.08 million||N/A||N/A|
Icon has higher revenue and earnings than ALGAE TEC LTD/S.
Risk & Volatility
Icon has a beta of 0.67, suggesting that its stock price is 33% less volatile than the S&P 500. Comparatively, ALGAE TEC LTD/S has a beta of 91.26, suggesting that its stock price is 9,026% more volatile than the S&P 500.
Institutional and Insider Ownership
86.4% of Icon shares are held by institutional investors. Comparatively, 0.1% of ALGAE TEC LTD/S shares are held by institutional investors. 44.0% of Icon shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
This is a summary of recent ratings and recommmendations for Icon and ALGAE TEC LTD/S, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|ALGAE TEC LTD/S||0||0||0||0||N/A|
Icon currently has a consensus price target of $148.56, indicating a potential upside of 9.84%. Given Icon’s higher probable upside, research analysts clearly believe Icon is more favorable than ALGAE TEC LTD/S.
Icon beats ALGAE TEC LTD/S on 10 of the 11 factors compared between the two stocks.
Icon Company Profile
ICON Public Limited Company, a clinical research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. It specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. The company's clinical development services include product development planning, strategic consulting, study protocol preparation, clinical pharmacology, pharmacokinetic and pharmacodynamic analysis, clinical research center, investigator site, patient recruitment, study monitoring and data collection, case report form preparation, statistical analysis, patient safety and risk-based monitoring, clinical data management, strategic analysis and data operation, regulatory consulting, and medical reporting and pharmacovigilance services. Its clinical development services also comprise interactive response technologies, electronic endpoint adjudication, medical imaging, adaptive trial design and execution, medical device and biosimilar trial, functional, strategic resourcing, sample analyses, safety testing, microbiology, custom flow cytometry, biomarker development, bioanalysis, immunoassay development, patient registries, outcomes research, health economics, market access and commercialization, drug price consulting, and healthcare and scientific communication services, as well as research trials for the U.S. government agencies, electronic transmission of test results, and electronic patient reported outcomes. The company was founded in 1990 and is headquartered in Dublin, Ireland.
ALGAE TEC LTD/S Company Profile
Affinity Energy and Health Limited operates as a plant-based health and wellbeing company in Australia, India, and the United States. It engages in developing technology to produce commercial quantities of algae and medicinal cannabis for supply to algae-based nutraceuticals, animal feed and aquaculture, medicinal cannabis, and biofuels markets. The company offers FeedMe Algae, an algae-based aqua feed; and algae-based biofuels. Affinity Energy and Health Limited was founded in 2007 and is based in Subiaco, Australia.
Receive News & Ratings for Icon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icon and related companies with MarketBeat.com's FREE daily email newsletter.